| Literature DB >> 33597186 |
Omar Silverman-Retana1,2, Stephanie Brinkhues3,4, Adam Hulman2, Coen D A Stehouwer5,6, Nicole H T M Dukers-Muijrers7,8, Rebecca K Simmons1, Hans Bosma3,9, Simone Eussen6,10, Annemarie Koster3,9, Pieter Dagnelie5,6, Hans H C M Savelberg11, Nicolaas C Schaper3,5, Martien C J M van Dongen3,10, Daniel R Witte12,2, Miranda T Schram5,6.
Abstract
INTRODUCTION: We compared the degree of spousal concordance in a set of detailed pathophysiological markers and risk factors for type 2 diabetes to understand where in the causal cascade spousal similarities are most relevant. RESEARCH DESIGN AND METHODS: This is a cross-sectional analysis of couples who participated in The Maastricht Study (n=172). We used quantile regression models to assess spousal concordance in risk factors for type 2 diabetes, including four adiposity measures, two dimensions of physical activity, sedentary time and two diet indicators. We additionally assessed beta cell function and insulin sensitivity and glucose metabolism status with fasting and 2-hour plasma glucose and hemoglobin A1c.Entities:
Keywords: diabetes mellitus; epidemiology; insulin resistance; risk factors; type 2
Year: 2021 PMID: 33597186 PMCID: PMC7893653 DOI: 10.1136/bmjdrc-2020-001879
Source DB: PubMed Journal: BMJ Open Diabetes Res Care ISSN: 2052-4897
Figure 1Sample exclusion flow chart. *Percentage of body fat had one observation less. AUC, area under the curve; HOMA2-IR, Homeostatic Model Assessment of Insulin Resistance.
The Maastricht Study spouses’ characteristics
| Characteristics | Men | Women |
| Median (IQR) | ||
| Sociodemographic | ||
| Age (years) | 62.0 (56.2–66.0) | 59.0 (53.0–64.0) |
| Risk factors | ||
| Physical activity dimensions (248) | ||
| Total wake time (min) | 943.9 (915.3–977.9) | 934.8 (899.5–972.6) |
| Mean stepping minutes per day | 121.3 (91.1–51.0) | 124.4 (102.3–146.2) |
| Time spent in HPA (%) | 1.5 (0.7–3.0) | 2.6 (1.4–3.7) |
| Time spent in LPA (%) | 10.4 (8.0–13.0) | 10.5 (8.6–12.1) |
| Sedentary time (%) | 62.4 (55.0–67.8) | 54.9 (48.7–61.2) |
| Diet indicators (307) | ||
| Dutch Healthy Diet Index | 80.1 (71.0–90.9) | 88.5 (80.5–97.1) |
| Total energy intake | 2351.1 (1952.5–2705.1) | 1912.1 (1650.8–2289.0) |
| Adiposity measures | ||
| BMI | 26.5 (24.4–28.9) | 24.8 (22.5–27.3) |
| Percentage of body fat (325) | 27.7 (24.5–32.2) | 37.9 (34.8–41.1) |
| Waist circumference | 99.1 (92.4–107.0) | 86.7 (80.1–94.3) |
| Hip circumference | 100.1 (97.0–105.0) | 99.1 (94.0–105.4) |
| Waist to hip ratio | 0.9 (0.9–1.0) | 0.8 (0.8–0.9) |
| Pathophysiological markers | ||
| Insulin sensitivity indices | ||
| HOMA2-IR (302) | 1.4 (1.0–2.1) | 1.1 (0.9–1.6) |
| Matsuda Index (269) | 3.1 (1.9–4.7) | 4.2 (2.6–5.7) |
| Beta cell function indices | ||
| C-peptidogenic indext30 (270) | 374.1 (235.6–561.4) | 423.3 (268.3–724.9) |
| Rate sensitivity index (pmol/m2/mM) (233) | 211.0 (116.4–368.9) | 208.2 (125.3–383.1) |
| C peptide AUC (269) | 187.5 (148.9–251.9) | 197.5 (159.8–250.8) |
| Glucose sensitivity index (pmol/min/m2/mM) (273) | 26.0 (17.8–36.9) | 27.2 (18.4–38.4) |
| Potentiation factor (284) | 1.5 (1.1–1.9) | 1.6 (1.2–2.1) |
| Disposition index (226) | 0.5 (0.3–0.8) | 0.8 (0.5–1.1) |
| Glucose metabolism indicators | ||
| Fasting plasma glucose (mmol/L) | 5.6 (5.2–6.1) | 5.2 (4.9–5.6) |
| 2-hour plasma glucose (mmol/L) (315) | 6.1 (4.8–8.0) | 5.7 (4.9–7.0) |
| Hemoglobin A1c (mmol/mol) (324) | 37.0 (34.0–41.0) | 37.0 (34.0–40.0) |
| Hemoglobin A1c (%) (324) | 5.6 (5.3–5.9) | 5.5 (5.3–5.8) |
If number is not specified in the first column brackets, then n=326.
AUC, area under the curve; BMI, body mass index; HOMA2-IR, Homeostatic Model Assessment of Insulin Resistance; HPA, high-intensity physical activity; LPA, low-intensity physical activity.
Sociodemographic characteristics, chronic disease background and behavioral risk factors from The Maastricht Study spouse relationships
| Affected individuals in the couples (n=326) | |||
| None | One | Two | |
| Sociodemographic characteristics (n) | |||
| Low educational level (318) | 35 (11.0) | 121 (38.3) | 160 (50.7) |
| Chronic disease background | |||
| Type 2 diabetes diagnosis | 236 (72.4) | 78 (24.0) | 12 (3.6) |
| Hypertension diagnosis | 70 (21.4) | 161 (49.3) | 95 (29.1) |
| History of cardiovascular disease (317) | 236 (74.5) | 72 (23.0) | 8 (2.5) |
| Family history of diabetes (237)* | 86 (36.3) | 82 (34.6) | 29 (12.2) |
| Behavioral risk factors | |||
| High alcohol consumption (320) | 178 (56.0) | 96 (30.0) | 45 (14.0) |
| Current smokers (321) | 273 (85.2) | 41 (12.8) | 6 (2.0) |
The table shows n (%). Numbers in brackets in the first column are the number of couples with available information on each indicator.
*In addition to the couples listed in the table (adding up to 83.1%) there were 9 couples (3.8%) where both partners had unknown family history and 31 couples (13.1%) where one partner had unknown family history and the other had no family history.
Spearman correlation coefficients and quantile regression models of the degree of spousal concordance in pathophysiological markers and type 2 diabetes risk factors
| n | rs (95% CI) | Men | Women | |||||
| n | Age-adjusted | Multivariable-adjusted | n | Age-adjusted | Multivariable-adjusted | |||
| Beta coefficient (95% CI) | Beta coefficient (95% CI) | |||||||
| Risk factors | ||||||||
| Physical activity dimensions | ||||||||
| Time in LPA | 248 | 0.27 (0.14 to 0.38) | 246 | 0.28 (0.13 to 0.58) | 0.33 (0.12 to 0.59) | 241 | 0.22 (0.11 to 0.34) | 0.18 (0.16 to 0.33) |
| Time in HPA | 248 | 0.36 (0.24 to 0.47) | 246 | 0.34 (0.20 to 0.48) | 0.35 (0.23 to 0.43) | 241 | 0.30 (0.14 to 0.59) | 0.28 (0.09 to 0.53) |
| Sedentary time | 248 | 0.17 (0.03 to 0.29) | 246 | 0.21 (−0.01 to 0.39) | 0.22 (0.01 to 0.37) | 241 | 0.16 (−0.02 to 0.31) | 0.11 (−0.02 to 0.34) |
| Diet indicators | ||||||||
| Dutch Healthy Diet Index | 307 | 0.42 (0.33 to 0.52) | 263 | 0.45 (0.28 to 0.61) | 0.42 (0.31 to 0.54) | 248 | 0.35 (0.21 to 0.51) | 0.29 (0.19 to 0.45) |
| Total energy intake | 307 | 0.26 (0.15 to0.36) | 263 | 0.25 (0.12 to 0.50) | 0.28 (0.12 to 0.47) | 248 | 0.32 (0.21 to 0.43) | 0.30 (0.18 to 0.41) |
| Adiposity measures | ||||||||
| BMI | 326 | 0.33 (0.24 to 0.42) | 272 | 0.31 (0.16 to 0.35) | 0.26 (0.20 to 0.35) | 254 | 0.21 (0.15 to 0.45) | 0.21 (0.05 to 0.35) |
| Percentage of body fat | 325 | 0.24 (0.14 to 0.34) | 271 | 0.33 (0.10 to 0.48) | 0.28 (0.06 to 0.49) | 253 | 0.20 (0.04 to 0.33) | 0.18 (0.01 to 0.28) |
| Waist circumference | 326 | 0.32 (0.22 to 0.43) | 272 | 0.36 (0.24 to 0.48) | 0.19 (0.07 to 0.32) | 254 | 0.20 (0.13 to 0.41) | 0.19 (0.10 to 0.35) |
| Waist to hip ratio | 326 | 0.21 (0.09 to 0.32) | 272 | 0.24 (0.03 to 0.39) | 0.09 (−0.06 to 0.31) | 254 | 0.18 (0.07 to 0.34) | 0.19 (0.00 to 0.30) |
| Pathophysiological markers | ||||||||
| Matsuda Index | 269 | 0.16 (0.03 to 0.28) | 233 | 0.06 (−0.05 to 0.13) | −0.00 (−0.08 to 0.11) | 225 | 0.19 (0.05 to 0.41) | 0.11 (−0.03 to 0.27) |
| HOMA2-IR | 302 | 0.19 (0.07 to 0.30) | 263 | 0.21 (0.03 to 0.49) | 0.07 (−0.01 to 0.30) | 253 | 0.13 (0.02 to 0.34) | 0.09 (0.03 to 0.19) |
| C-peptidogenic indext30 | 270 | 0.10 (−0.01 to 0.22) | 234 | 0.03 (−0.02 to 0.13) | 0.03 (−0.03 to 0.12) | 226 | 0.16 (0.05 to 0.43) | 0.15 (0.03 to 0.42) |
| Rate sensitivity | 233 | 0.11 (−0.01 to 0.24) | 202 | 0.18 (−0.10 to 0.32) | 0.17 (−0.09 to 0.28) | 197 | 0.11 (−0.06 to 0.22) | 0.13 (−0.07 to 0.20) |
| C peptide AUC | 269 | 0.07 (−0.05 to 0.19) | 233 | 0.13 (−0.09 to 0.24) | 0.07 (−0.04 to 0.20) | 225 | 0.05 (−0.05 to 0.32) | 0.05 (−0.07 to 0.31) |
| Glucose sensitivity | 273 | 0.09 (−0.02 to 0.21) | 239 | 0.04 (−0.09 to 0.33) | 0.07 (0.01 to 0.18) | 231 | 0.04 (−0.09 to 0.26) | 0.03 (−0.12 to 0.22) |
| Potentiation factor | 284 | −0.00 (−0.11 to 0.11) | 246 | 0.01 (−0.11 to 0.07) | 0.00 (−0.14 to 0.07) | 237 | 0.03 (−0.14 to 0.17) | 0.09 (−0.10 to 0.19) |
| Disposition index | 268 | 0.23 (0.10 to 0.35) | 232 | 0.12 (0.04 to 0.24) | 0.09 (−0.01 to 0.16) | 224 | 0.26 (0.20 to 0.52) | 0.15 (0.01 to 0.48) |
| Glucose metabolism indicators | ||||||||
| Fasting glucose | 326 | 0.25 (0.14 to 0.34) | 280 | 0.37 (0.07 to 0.56) | 0.30 (0.05 to 0.51) | 269 | 0.17 (0.06 to 0.30) | 0.12 (0.05 to 0.22) |
| 2-hour plasma glucose | 308 | 0.15 (0.03 to 0.27) | 276 | 0.15 (−0.00 to 0.31) | 0.07 (−0.02 to 0.16) | 262 | 0.06 (0.01 to 0.18) | 0.10 (−0.05 to 0.16) |
| Hemoglobin A1c | 324 | 0.20 (0.09 to 0.30) | 282 | 0.23 (0.01 to 0.36) | 0.15 (−0.05 to 0.30) | 267 | 0.10 (−0.04 to 0.22) | 0.08 (−0.00 to 0.19) |
rs is Spearman correlation coefficient.
Physical activity dimensions were adjusted for age, educational level, alcohol use and smoking status. The Dutch Healthy Diet Index was adjusted for age, educational level, waist circumference, smoking status and total energy intake. Adiposity measures were adjusted for age, time in HPA, smoking status, Dutch Healthy Diet Index and educational level. Pathophysiological markers were adjusted for age, waist circumference, time in HPA and family history of diabetes.
AUC, area under the curve; BMI, body mass index; HOMA2-IR, Homeostatic Model Assessment of Insulin Resistance; HPA, high-intensity physical activity; LPA, low-intensity physical activity.
Figure 2Age-adjusted quantile regression models in the complete case analysis sample (n=172) comparing the degree of spousal concordance in the different sets of outcomes sorted by decreasing order and separately for men and women. Beta coefficients with 95% CI. Blue lines represent men’s outcomes with wives’ measurements as exposure. Red lines represent women’s outcomes with husbands’ measurements as exposure. AUC, area under the curve; BMI, body mass index; HbA1c, hemoglobin A1c; HOMA2-IR, Homeostatic Model Assessment of Insulin Resistance; PA, physical activity.